OPTIBIOTIX HEALTH PLC Logo

OPTIBIOTIX HEALTH PLC

Develops microbiome-modulating ingredients to manage chronic lifestyle diseases.

OPTI | IL

Overview

Corporate Details

ISIN(s):
GB00BP0RTP38
LEI:
213800UKYQFT941QHS14
Country:
United Kingdom
Address:
Innovation Centre Innovation Way, YO10 5DG York

Description

OptiBiotix Health PLC is a life sciences company specializing in the research and development of technologies that modulate the human microbiome. The company identifies and develops microbial strains, compounds, and formulations for use as food ingredients, dietary supplements, and active compounds. Its primary focus is on the prevention and management of chronic lifestyle diseases, including obesity, cardiovascular health issues such as high cholesterol, and diabetes. OptiBiotix's approach is founded on strong scientific evidence, with its product pipeline supported by clinical human studies. The company provides these clinically proven ingredients and white-label solutions to partners in the food, health, and wellness sectors.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-24 08:20
SweetBiotix Overview and Update
English 21.4 KB
2025-11-17 08:35
Order with well-known Weight Management Company
English 14.9 KB
2025-10-02 08:00
Director/PDMR Shareholding
English 33.8 KB
2025-09-24 13:28
Director/PDMR Shareholding
English 43.8 KB
2025-09-16 08:00
Half-year Report
English 230.4 KB
2025-08-21 08:00
Admission to Trading on the OTCQB Venture Market
English 14.4 KB
2025-08-20 08:00
Agreement with Weight Management Company
English 15.1 KB
2025-08-14 08:00
Launch of SlimBiome in leading US brand
English 17.0 KB
2025-08-06 17:08
Result of AGM
English 13.9 KB
2025-08-06 08:00
Issue of Options
English 31.2 KB
2025-07-28 08:00
Trading update
English 19.1 KB
2025-06-30 08:00
Final Results
English 544.3 KB
2025-06-30 08:00
Change of Broker
English 11.6 KB
2025-06-11 08:00
SlimBiome® study in European Journal of Nutrition
English 28.0 KB
2025-05-23 08:00
Placing and Issue of Warrants
English 20.6 KB

Automate Your Workflow. Get a real-time feed of all OPTIBIOTIX HEALTH PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for OPTIBIOTIX HEALTH PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for OPTIBIOTIX HEALTH PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.